
Bloomberg Intelligence Live Nation Reaches DOJ Settlement in Antitrust Case
Mar 9, 2026
Jennifer Rhee, senior litigation analyst who explains the DOJ settlement with Live Nation and its likely amphitheater divestitures. Madison Muller, health reporter covering pharma industry moves, on Novo Nordisk’s renewed deal with Hims & Hers for weight‑loss drugs. Deborah Aitken, luxury goods analyst, on how Middle East conflict could dent luxury growth. Bess Freedman, NYC real estate CEO, on geopolitical risk, cash buyers, and housing supply constraints.
AI Snips
Chapters
Transcript
Episode notes
Amphitheater Divestiture Is Central To DOJ Deal
- DOJ settlement likely requires Live Nation to divest large amphitheaters to open them to other promoters.
- DOJ alleged Live Nation owned 60 of the top 100 U.S. amphitheaters, and selling some would let non-Live Nation promoters host summer tours.
Ticketmaster Likely Stays With Live Nation For Now
- The DOJ settlement does not force Ticketmaster sale, but several states may keep litigating for divestiture.
- New York objected and could seek a judge-ordered breakup, though Jennifer Rhee calls that remedy a long shot.
Behavioral Remedies May Be Ineffective Against Live Nation
- Skepticism that behavioral conditions in the settlement will fix consumer ticketing problems.
- Live Nation has been under a 2010 consent order and allegedly skirted behavioral terms repeatedly, making new behavioral fixes uncertain.
